ORACLE INVESTMENT MANAGEMENT INC

CIK 00010126224 companiesGREENWICH, CT

SEC Profile

Transactions

Companies

Filings

CIK

0001012622

Recent Transactions

19 trades

Purchase
BIOLASE, INC
Common Stock
2017-12-05$0.46/sh+10,745,615→ 30,866,265 total
Purchase
BIOLASE, INC
Common Stock
2017-12-04$0.30/sh+1,800,000→ 20,120,650 total
Exercise of In-Money
Aspira Women's Health Inc.$AWHL
Warrants to acquire Common Stock
2017-08-31−583,333→ 0 total
Exercise of In-Money
Aspira Women's Health Inc.$AWHL
Common Stock
2017-08-31$1.00/sh+583,333→ 9,825,289 total
Expiration (Short)
Aspira Women's Health Inc.$AWHL
Warrants to acquire Common Stock
2017-08-25−583,333→ 0 total
Purchase
Aspira Women's Health Inc.$AWHL
Warrants to acquire Common Stock
2017-08-25+583,333→ 583,333 total
Purchase
Aspira Women's Health Inc.$AWHL
Warrant to acquire Common Stock
2017-02-17+1→ 0 total
Purchase
Aspira Women's Health Inc.$AWHL
Common Stock, par value $0.001 per share
2017-02-17$1.40/sh+617,731→ 9,825,289 total
Purchase
Aspira Women's Health Inc.$AWHL
Common Stock, par value $0.001 per share
2015-07-14$1.91/sh+1,839→ 8,624,225 total
Purchase
Aspira Women's Health Inc.$AWHL
Common Stock, par value $0.001 per share
2015-07-14$1.96/sh+510,204→ 8,624,225 total
Purchase
Aspira Women's Health Inc.$AWHL
Common Stock, Par Value $0.001 per share
2014-12-23$1.44/sh+972,222→ 8,112,182 total
Purchase
Aspira Women's Health Inc.$AWHL
Warrants to acquire Common Stock
2014-12-23+583,333→ 0 total
Conversion
Aspira Women's Health Inc.$AWHL
Warrants to acquire Common Stock
2013-12-19−4,339,980→ 0 total
Conversion
Aspira Women's Health Inc.$AWHL
Common Stock, par value $0.001 per share
2013-12-19+4,339,980→ 7,139,960 total
Sale
Oncternal Therapeutics, Inc.
Common Stock
2004-08-16$8.50/sh−345,000→ 2,292,360 total
Conversion
Oncternal Therapeutics, Inc.
Series D Preferred Stock
2004-02-06−727,430→ 0 total
Conversion
Oncternal Therapeutics, Inc.
Series C Preferred Stock
2004-02-06−1,764,297→ 0 total
Conversion
Oncternal Therapeutics, Inc.
Common Stock
2004-02-06+2,637,360→ 2,637,360 total
Conversion
Oncternal Therapeutics, Inc.
Series E Preferred Stock
2004-02-06−145,633→ 0 total

Companies

Recent Filings

Address

200 GREENWICH AVENUE

GREENWICH, CT, 06830

View on SEC.gov